I found this juxtaposition of facts telling:

> Drug design: Using Mythos 5, our internal protein design experts accelerated... Nine of the 14 protein targets from this study (shown below) yielded strong candidates for *drug design that we’re currently investigating*.

(emphasis mine)

> queries that are beneficial in the hands of cybersecurity professionals and biology researchers could be dangerous if available to malicious actors... When Fable’s classifiers detect a request related to cybersecurity, *biology and chemistry*, or distillation, the response is automatically handled by Claude Opus 4.8 instead.

All of the things they are nerfing are things that they also intend to profit from themselves.

- Cybersecurity - selling this to companies and US gov through "Glass Wing".

- Selling inference (distillation risk).

- And now, drug design.

I'm extrapolating "currently investigating" to "are going to monetize" but I don't think that's a big stretch. They appear to be using safety as a cover for anti-competitive behaviour.